• Author: Andrew W. Bismark
Clear all

Impact of medical comorbidities on ketamine and esketamine treatment effectiveness for posttraumatic stress disorder and depression: A clinical outcomes analysis from the VA San Diego Healthcare System

Abstract: BACKGROUND: Ketamine and esketamine are increasingly used to manage treatment-resistant depression and have also been shown to reduce symptoms of posttraumatic stress …

Ketamine-occasioned mystical experience in Veterans with treatment-resistant depression: A retrospective exploratory analysis

Abstract: Introductions: Mystical experiences are powerful experiences that may have therapeutic value. Ketamine, a dissociative anesthetic, has shown potential to induce mystical …

MDMA-assisted brief cognitive behavioral conjoint therapy for PTSD: Study protocol for a pilot study

Abstract: Background: Posttraumatic Stress Disorder (PTSD) impacts both individual and relational functioning. Veteran couples are at increased risk of relationship distress due to …

The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: A retrospective clinical study

Abstract: STUDY OBJECTIVES: Intranasal administration of esketamine is Food and Drug Administration-approved for treatment-resistant depression. In a recent retrospective case …